Biogen Inc.’s stock rose 2% early Tuesday, after the company and Belgian partner UCB announced positive results in a late-stage trial
More Stories
Here’s just how much Apple’s business is dependent on the iPhone
Apple gets about half of its revenue directly from iPhone sales. But the product is indirectly responsible for far more...
The stock market has become less efficient — the culprit might surprise you
Increasing inefficiency doesn’t mean that it’s easier to beat the market, says Cliff Asness.
Nio’s stock gets a big boost from China’s broad economic stimulus measures
Nio’s stock was surging Tuesday, as investors in the China-based electric vehicle maker cheered the stimulus measures China’s central back...
Home prices grew at the slowest pace in 8 months, Case Shiller says, but still inch up to new record high
Case-Shiller 20-city home price index rose 5.9% year-on-year in July.
Starbucks downgraded as analyst cites execution challenges ahead
Starbucks Corp. was downgraded by Jefferies Tuesday, as the analyst firm highlighted a number of hurdles in the path of...
KKR’s Pete Stavros launches group promoting stock ownership for employees
Pete Stavros, a high-ranking executive at private-equity firm KKR & Co. Inc. known for rewarding staff with stock, on Tuesday...